Komipharm International Co. Ltd (041960) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Based on the latest financial reports, Komipharm International Co. Ltd (041960) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩946.94 Million ≈ $641.73K USD) by net assets (₩72.06 Billion ≈ $48.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Komipharm International Co. Ltd (041960) liquidity interval to measure how many days the company can operate on defensive assets alone.

Komipharm International Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Komipharm International Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Komipharm International Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Komipharm International Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fagerhult AB ST:FAG	0.049x
Auk Corp KO:017900	0.002x
SIMONA AG O.N. F:SIM0	N/A
Suncha Technology Co Ltd SHE:001211	0.051x
Super Group Ltd. JSE:SPG	0.109x
Bpost NV BR:BPOST	0.252x
Jumbo Interactive Ltd AU:JIN	0.185x
Rapac Communication & Infrastructure Ltd TA:RPAC	-0.017x

Annual Cash Flow Conversion Efficiency for Komipharm International Co. Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Komipharm International Co. Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Komipharm International Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.06 Billion ≈ $48.83 Million	₩-621.80 Million ≈ $-421.39K	-0.009x	-106.39%
2024-12-31	₩65.54 Billion ≈ $44.41 Million	₩8.85 Billion ≈ $6.00 Million	0.135x	+389.35%
2023-12-31	₩60.02 Billion ≈ $40.67 Million	₩-2.80 Billion ≈ $-1.90 Million	-0.047x	-56.46%
2022-12-31	₩60.63 Billion ≈ $41.09 Million	₩-1.81 Billion ≈ $-1.23 Million	-0.030x	-57.78%
2021-12-31	₩66.46 Billion ≈ $45.04 Million	₩-1.26 Billion ≈ $-851.13K	-0.019x	-5819.79%
2020-12-31	₩76.28 Billion ≈ $51.69 Million	₩25.20 Million ≈ $17.08K	0.000x	-97.45%
2019-12-31	₩73.28 Billion ≈ $49.66 Million	₩950.79 Million ≈ $644.34K	0.013x	+160.06%
2018-12-31	₩93.39 Billion ≈ $63.29 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.022x	-1028.56%
2017-12-31	₩101.27 Billion ≈ $68.63 Million	₩235.64 Million ≈ $159.69K	0.002x	-82.06%
2016-12-31	₩93.20 Billion ≈ $63.16 Million	₩1.21 Billion ≈ $819.00K	0.013x	+133.70%
2015-12-31	₩76.13 Billion ≈ $51.59 Million	₩-2.93 Billion ≈ $-1.98 Million	-0.038x	+19.33%
2014-12-31	₩53.16 Billion ≈ $36.02 Million	₩-2.54 Billion ≈ $-1.72 Million	-0.048x	-154.21%
2013-12-31	₩44.72 Billion ≈ $30.31 Million	₩3.93 Billion ≈ $2.67 Million	0.088x	--

About Komipharm International Co. Ltd

KQ:041960 Korea Pharmaceuticals

Market Cap

$338.89 Million

₩500.07 Billion KRW

Market Cap Rank

#14344 Global

#461 in Korea

Share Price

₩8650.00

Change (1 day)

-2.15%

52-Week Range

₩5180.00 - ₩10310.00

All Time High

₩43026.96